Aim: To study remote results and the role of intraarterial chemotherapy with local hyperthermia in the treatment of nasal and paranasal sinus cancer patients. Methods: 209 patients were treated over the period 2000 -2008. T 3 stage was diagnosed in 106 patients (51.4%) and T 4 stage in 103 (48.6%) patients. Squamous cell carcinoma was found in 71.3% patients. Patients were divided into 4 groups: 1) intraarterial chemotherapy with local hyperthermia and radiotherapy (58 patients; 2) intraarterial chemotherapy and radiotherapy (48 patients;, 3) systemic chemotherapy and radiotherapy (58 patients); 4) radiotherapy followed by surgery (45 patients). We used the following regimen: cisplatin 100 mg, fluorouracil 3000 mg and doxorubicin 60 mg. In 1 st group 58 patients received local UHF-hyperthermia with the frequency of 40 MHz increasing the temperature up to 41-43°C in the tumour. Patients of the 1 st and 2 nd groups, received intraarterial chemotherapy with ligation and catheterization of external carotid artery. All patients received telegammatherapy, dose 40-60 Gy. For appreciating of the remote results SPSS-16 statistical methods were used. Results: Continuous regional intraarterial chemical induction in the background of local hyperthermia significantly increased the results of treatment. Surgical treatment was made to 128 (61.2%) patients at second grade of complex therapy. In the 1 st group of patients 3-year survival rate was 83.4%, and 5-year survival rate was 73.0%. In the 2 nd group those rates were 80.4% and 66.7%, respectively. In the 3 rd group those rates were 68.2% and 60.6%, respectively. In the 4 th group those rates were 68.1% and 54.1%, respectively. In the study of long-term treatment outcomes of patients receiving integrated and combined treatment it was found that the recurrence rate in the 1 st and 2 nd groups compared with the 3 rd and 4 th groups of patients differed significantly. So in the 1 st group these figures were 32.4% in the 2 nd group 38.1%, and in the third group recurrence was seen in 45.4% of patients. In the 4 th group this figure increased further and was observed in 51.3% of patients. Conclusions: Thus, neoadjuvant continuous intraarterial chemotherapy with local UHF-hyperthermia and radiotherapy in the 1 st group of patients allowed us to increase significantly the remote results compared with those in the 3 rd group who received systemic chemotherapy. Disclosure: All authors have declared no conflicts of interest.
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